Presentation TCT 2022 TCT 155: The Bioadaptor RCT Study: Comparison of a Novel Sirolimus-Eluting Bioadaptor with Zotarolimus-Eluting Stent in de novo Coronary Arteries Presenter: Holger Nef September 19, 2022
Presentation TCT 2022 TCT 64: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 3 Clinical Year Outcomes Presenter: Matthias Lutz September 17, 2022
Presentation TCT 2022 TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes Presenter: Matthias Lutz September 17, 2022
News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022